John Seykora, MD
Dermatopathology · Philadelphia, PANPI 1205851888
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,650 of the $18,822 with a category attached, or 99.1%. Merck accounts for 99.2% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $8,150 and has fallen 77.5% since, to $1,835 in 2025. Among dermatopathology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 18 payments — averaging $1045.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$19K
- Almirall LLC$150
Across 11 payments — averaging $76,312 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Almirall LLC$436K
- Merck$357K
- GSK$46K
What the payments were for
- Consulting fees$18,65099%
- Travel & lodging$220%
- Food & beverage$1501%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 17 | $18,672 |
| Almirall LLC | 1 | $150 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$8,735
How this compares
$18,822 in reported general payments places this provider in the 95th percentile of 27 dermatopathology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatopathology in Philadelphia
- Debra JihPhiladelphia$2K
- Jina ChungPhiladelphia$918
- Alicia RosenPhiladelphia$252
- Herbert AllenPhiladelphia$203
- Michael MingPhiladelphia$133
- Elizabeth SpiersDoylestown$65K
- Christine StankoVillanova$5K
- Basil PatelYardley$4K
- Victoria Cirillo HylanBryn Mawr$4K
- Howard AltmanAllentown$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.